August 18, 2023

To Kegel or Not to Kegel: A Guide for Women with Pelvic Organ Prolapse

One way to manage POP is through Kegel exercises, but the effectiveness of Kegels can vary. In this article, we’ll explore whether or not to Kegel, which types of prolapse can benefit from Kegels, other exercises that can help manage POP, and more.
August 14, 2023

Coping with Post-Partum Pelvic Organ Prolapse at a Young Age

POP can affect any woman at any point in life, but being diagnosed with it at a young age, especially right after childbirth, can be overwhelming.
May 16, 2023

FemTherapeutics Raises $1.8 Million To Advance Women’s Health With Its Patient-Specific Gynecological Prosthetics

Forbes features FemTherapeutics' success in raising $1.8 million for developing personalized gynaecological prosthetics.
May 9, 2023

Is Pelvic Organ Prolapse Reversible?

Is Pelvic Organ Prolapse Reversible?     Receiving a diagnosis of any medical condition can be a daunting experience, filled with uncertainty and questions about the […]
April 9, 2023

FemTherapeutics Awarded Innovations for Equity at WIN:Women in Innovation Gala 2022

Winners were announced live at the WIN Awards Gala on September 23, 2022 at Company in New York City.
February 8, 2023

FemTherapeutics winner of HITLAB Women’s Health Tech Challenge 2023

New York, NY February 8, 2023 — On Friday, February 10th, HITLAB Women’s Health Tech Initiative will host its fifth annual Women’s Health Tech (WHT) Challenge, where eight promising FemTech founders will pitch their disruptive healthcare solutions to a panel of judges in an effort to discover the next wave of innovation that can address the unmet needs within Women’s Health.
November 3, 2022

FemTherapeutics wins $150 000 in investment as the first prize award for SheBoot with InvestOttawa

Negin Ashouri, Co-founder & CEO, and Inara Lalani, Co-founder & COO of FemTherapeutics Inc., a Canadian-based medical device company specializing in the development of the world’s first customizable gynecological prosthetic: Top prize winner with $150,000 in investment.
September 28, 2022

How international entrepreneurs are finding success with start-ups in Montréal

Montréal is developing a strong ecosystem for start-ups across a range of industries, thanks to a series of initiatives that are attracting international entrepreneurs. These include Negin Ashouri – co-founder of FemTherapeutics, which is developing a revolutionary implant to treat conditions in gynaecology.
September 15, 2022

McGill University: Spotlight on FemTherapeutics

At Montreal-based FemTherapeutics, cofounder and Chief Operating Officer Inara Lalani (BCom’20) is helping lead efforts to harness the power of new technologies—such as 3D printing and artificial intelligence—to bring pessaries into the 21st century.
Contact Us
FemTherapeutics

Sign up for our newsletter to stay informed on our product launches and key updates


1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

Sign up for our newsletter to stay informed on our product launches and key updates


1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

Dr. Mihnea Gangal


Dr. Mihnea Gangal is a practicing urogynecologist at the Notre Dame Hospital and St. Mary’s Hospital in Montreal Quebec. He has completed his Masters in Surgical Innovation, Residency in Obstetrics and Gynecology, and Fellowship in Urogynecology from McGill University. He was one of the first performers of the vNOTE surgery in Montreal and continues to provide proctoring for various innovative surgical techniques.

Negin Ashouri


Negin Ashouri is the Co-founder and CTO at FemTherapeutics. Growing up in Iran, Negin has always had the passion to fix broken objects since she was 4-years-old. This habit continued throughout her life and she quickly realized engineering would become her passion among other sciences. She has always fought for human rights and especially women's rights in a country where it has been neglected. She decided to travel abroad to broaden her knowledge in technology in developed countries. She began her Masters’ studies in Computer Science at Concordia University, focused in the field of applying AI in Medicine and focused on detecting cervical cancer. Her interest in gynecology spurred as a result of her untreated medical conditions in Iran, and her interest to advance women’s health for all. She has been named 1 of the top 5 up and upcoming entrepreneurs in Canada by Mitacs in 2021.

Inara Lalani


Inara is the Co-Founder & CEO of FemTherapeutics Inc. Growing up, Inara had the opportunity to live in several countries, including Pakistan, Singapore, Thailand, Indonesia, Poland, Qatar, and Canada. Her experiences in these diverse communities inspired her interest in social business and her commitment to addressing socioeconomic inequalities. During her time at McGill University. In 2020, Inara graduated with a BCom focused on Information Systems and Entrepreneurship, fueling her desire to eventually become an entrepreneur. Inara has spoken on various panels, podcasts, and conferences globally, focusing on women's entrepreneurship, gender health equity, and youth involvement. In recognition of her achievements, Inara was named one of Bay Street Bull's Women of the Year in 2022. She is also a certified board governance leader and has supported many community-driven initiatives.


Sign up for our newsletter to stay informed on our product launches and key updates


1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

 

Sign up for our
Newsletter

stay informed on our product
launches and key updates.


1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder